That's crucial, since the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work. Simply put, we have to understand how these proteins fold if we desire a drug to work. Historically, this has been an experimental process (white house). However now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're designed to do. This was an advancement nearly nobody noticed. But it's going to have extensive ramifications for treating illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be lots of investment opportunities in this area, too. Moving topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown prediction). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it drew back maybe considerably prior to going higher - jeff brown latest prediction. I've been covering bitcoin for a long period of time now. Among the very first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mainly educating readers. However that's not the huge concern anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. brownstone research stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of terrific personal companies on the brink of hitting the public markets And I have actually been working on a brand-new way for you to invest even before these companies go public.
This opportunity has been developing over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to book your spot for free.
Emma Walsh here, managing editor of the Diary. Regular Diary readers know that tech isn't our typical beat (last year). And when it pertains to tech investing, we leave it to the specialists. The good news is, we have numerous such specialists in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing experts we understand (jeff brown biotech stocks). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the big picture and forecast what's just around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and a lot more. These trends are experiencing exponential growth and creating extraordinary opportunities for investors. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. jeff brown genetic sequencing stock. But in spite of what lots of readers may think, this is a trend that's just starting. Even though the COVID-19 pandemic disrupted supply chains in 2015, an impressive 250 million 5G-enabled devices were still offered.
And all of this ultimately caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown prediction for 2021). Losing 2 months of production and sales actually affects the number of 5G devices are offered in the calendar year. When you consider all of that, selling 250 million systems is amazing. More importantly, the hold-ups triggered by the pandemic developed a load of suppressed need. Which demand is now going to be pressed into 2021. In truth, I anticipate that more than 500 million 5G devices will be shipped in 2021 - jeff brown genetic sequencer stock. Which's not my only 5G prediction When I have actually talked about 5G in the past, I have actually described its 3 different phases.
In Stage 2, 5G devices go on sale. 5G phones and other products begin to reach consumers. And in Phase Three, 5G services start to be used (jeff bezos). That's when we start to see applications working on 5G networks. Believe of things like enormous multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Stage Three by this summer season. This starts something of a virtuous cycle: Many people don't truly appreciate the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In truth, 5G is going to open a suite of incredible applications: self-driving cars and trucks, the Internet of Things, robotic surgery, and more. All of these innovations require 5G. The investment opportunities going forward will be massive. Stepping away from 5G, the next essential innovation I predict in 2021 is CRISPR hereditary editing. CRISPR represents "clustered routinely interspaced brief palindromic repeat." It's a mouthful. However it's one of the most amazing developments in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software.
The program can crash or not work correctly. CRISPR uses a comparable idea but with our hereditary code. "Typos" in our genome can result in illness. CRISPR can correct these "typos." For many years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And throughout that time, there were actually only 3 business running in this area. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual results. We're treating illness and seeing that this technology simply works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and providing amazing returns. This entire industry is effectively a greenfield opportunity.
There's space for many companies to exist in this space. brownstone research stock. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or three more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its latest Alpha, Fold software application can accurately forecast the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That's crucial since the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error procedure. And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however a number of drug therapies produced utilizing this technology. This was among those breakthroughs that almost nobody saw. However it's going to have extensive implications for treating disease. And, obviously, there will be plenty of investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it drew back possibly significantly prior to going greater. I have actually been covering bitcoin for a long period of time now. One of the very first research study reports I ever published was on bitcoin - future report. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. But at the time of that initial recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
However nobody is asking that concern anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. last week. Mass, Mutual is a 150-year-old institution. So believe about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the details depends on date since February 2021, but we might not independently confirm this claim. Given Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like capability to choose winning technology stocks. He spent more than 25 years looking into innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an exceptional viewpoint on the market. He's always on the hunt for new opportunities, and he shares much of his finest picks in the Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an excellent reputation as a stock-picker, and he effectively predicted some of the most significant financial occasions of the previous twenty years. Although he doesn't appear to launch his choices to the public, the service's success is a direct indicator of Brown's stock-picking prowess. Nobody on Wall Street gets it best each time, but Jeff Brown's precise predictions have earned him legions of devoted followers. That says a lot about his capability. The Future Report is released by Brownstone Research, a popular financial research publisher. Brownstone Research uses a number of research study services with a variety of expertises - tech stocks.
The company is likewise associated with Bonner & Partners, another well-respected research study publisher - last year. On its website, Brownstone states its mission is to supply retail investors with professional-grade research study: "For too long, the best investment research has not been readily available to specific investors. It has been typically reserved for financial investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown top biotech 2020. The mission of Brownstone Research study is to make that type of proprietary research offered to any investors wanting to get an edge in the markets. The objective is easy to provide distinct and profitable investment research discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise acts as the firm's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of consistent success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout the majority of America. If you know even a little bit about the marketplace, you know that he has a track record as a King Midas of sorts. jeff brown 1 biotech. Everything he touches relies on gold! Jeff is well mindful of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge task.
In reality, Brown thinks S.A.V. jeff brown stock predictions. could be "the biggest pattern of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be weding 2 advanced technologies: expert system and electrical cars and trucks. Musk hopes the combination will help him establish the very first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the vehicle market's Holy Grail. As you know, electric vehicles and self-driving cars and truck stocks have actually been substantial this year, however the Wall Street machine has approved hype without much tangible result. In spite of an extreme boost in competitors over the past few years, Brown still thinks Musk has the finest possibility of putting everything together.
tech could be the magic string that ties it all together. S.A.V. stands for Shared Autonomous Vehicle, and it could be the future of transport. Basically, this innovation would allow you to lease out your vehicle as a self-governing, self-driving taxi when you're not using it. You just leave the automobile and press a button on an app that informs the automobile to "sign up with the fleet." Next thing you know, you're unwinding on your couch while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a substantial portion of the profits. It sounds crazy, but it might be closed than you believe.